20 LATEST RESOURCES (144 INDEXED)
Methadone Treatment for Opioid Use Disorder – Improving Access through Regulatory and Legal Change: Proceedings of a Workshop (Meetings-Events) · July 2022
Publications (Books-Reports)
National Academies Press
OROS-Methylphenidate to Reduce ADHD Symptoms in Male Prisoners Aged 16-25 Years: A RCT · July 2022
Publications (Books-Reports)
National Institute for Health and Care Research
Utilization of Cholinesterase Inhibitors for Alzheimer’s Disease in Canada · June 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Monitoring Patients with Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy · June 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Comparative Study between Herbal and Synthetic Antidepressant Drugs (Medicinal Plants) · June 2022
Publications (Chapters)
IntechOpen Books
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings · December 2021
Publications (Books-Reports)
Substance Abuse and Mental Health Services Administration
Antipsychotic Drugs or Benzodiazepines for Rapid Tranquilization in Mental Health Facilities or Emergency Department Settings · August 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia) · April 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Bupropion for Treatment Resistant Depression · April 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Psychological Intervention, Antipsychotic Medication or a Combined Treatment for Adolescents with a First Episode of Psychosis: The MAPS Feasibility Three-Arm RCT · January 2021
Publications (Books-Reports)
National Institute for Health Research
Nicotine Replacement Treatment, E-Cigarettes and an Online Behavioural Intervention to Reduce Relapse in Recent Ex-Smokers: A Multinational Four-Arm RCT · December 2020
Publications (Books-Reports)
National Institute for Health Research
Fluoxetine to Improve Functional Outcomes in Patients After Acute Stroke: The FOCUS RCT · May 2020
Publications (Books-Reports)
National Institute for Health Research
Lurasidone Hydrochloride for Bipolar Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Quetiapine for Major Depressive Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Varenicline versus Nicotine Replacement Therapy for Long-Term Smoking Cessation: An Observational Study Using the Clinical Practice Research Datalink · February 2020
Publications (Books-Reports)
National Institute for Health Research
Clozapine Initiation for Schizophrenia: A Review of Clinical Effectiveness and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Intranasal and Intramuscular Naloxone for Opioid Overdose in the Pre-Hospital Setting: A Review of Comparative Clinical and Cost-Effectiveness, and Guidelines · December 2019
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Administration of Naloxone in a Home or Community Setting: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines · December 2019
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Antidepressant Treatment with Sertraline for Adults with Depressive Symptoms in Primary Care: The PANDA Research Programme Including RCT · December 2019
Publications (Books-Reports)
National Institute for Health Research
Administration of Naloxone in a Home or Community Setting: A Rapid Qualitative Review · December 2019
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health